Shanghai Creation Investment
8
19M
7
0.44
3
0.12
2
- Areas of investment
Summary
Shanghai Creation Investment appeared to be the VC, which was created in 2006. The leading representative office of defined VC is situated in the Shanghai. The venture was found in Asia in China.
The high activity for fund was in 2016. The fund is generally included in less than 2 deals every year. The real fund results show that this VC is 55 percentage points more often commits exit comparing to other companies. Comparing to the other companies, this Shanghai Creation Investment performs on 4 percentage points less the average number of lead investments. The common things for fund are deals in the range of 5 - 10 millions dollars.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Shanghai Creation Investment, startups are often financed by General Technology Venture Capital. The meaningful sponsors for the fund in investment in the same round are ZGC Group, Waarde Capital, Robert Bosch Venture Capital. In the next rounds fund is usually obtained by Avacare Health Group.
Among the most successful fund investment fields, there are Energy, Clinical Trials. For fund there is no match between the location of its establishment and the land of its numerous investments - Israel. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Biop-Medical, Cygnus Biosciences. The fund has exact preference in a number of founders of portfolio startups.
We also calculated 3 valuable employees in our database.
Investments analytics
Analytics
- Total investments
- 8
- Lead investments
- 3
- Exits
- 2
- Rounds per year
- 0.44
- Follow on index
- 0.12
- Investments by industry
- Manufacturing (5)
- Biotechnology (4)
- Medical (4)
- Medical Device (3)
- Health Diagnostics (2) Show 10 more
- Investments by region
-
- China (5)
- Israel (2)
- Canada (1)
- Peak activity year
- 2016
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 165M
- Group Appearance index
- 0.62
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Shende Medical Equipment Technology | 06 Jul 2021 | Biotechnology, Manufacturing, Medical Device, Medical | Early Stage Venture | 15M | Shanghai, Shanghai, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.